Previous Close | 335.83 |
Open | 335.16 |
Bid | 344.02 x 900 |
Ask | 346.72 x 800 |
Day's Range | 334.79 - 347.44 |
52 Week Range | 298.69 - 401.78 |
Volume | |
Avg. Volume | 983,575 |
Market Cap | 47.458B |
Beta (5Y Monthly) | 0.59 |
PE Ratio (TTM) | 15.43 |
EPS (TTM) | 22.46 |
Earnings Date | May 03, 2023 - May 08, 2023 |
Forward Dividend & Yield | 2.16 (0.64%) |
Ex-Dividend Date | Feb 28, 2023 |
1y Target Est | 429.75 |
Subscribe to Yahoo Finance Plus to view Fair Value for MCK
McKesson (NYSE: MCK), a healthcare supplier that was founded in 1833, is a value investor's dream. The company has seen its shares rise more than 15% over the past year, though they have fallen more than 7% so far in 2023. McKesson recently raised its guidance for fiscal 2023, citing operational momentum.
In the latest trading session, McKesson (MCK) closed at $341.82, marking a -1.63% move from the previous day.
Broyhill Asset Management, a boutique investment firm, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. The portfolio gained 1.3% net of fees and expenses in 2022 compared to a -18% return for the MSCI World Index. The portfolio compounded at 12.3% annually net of fees and expenses, since […]